Clinical trials
Phase 2 Cardiovascular Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroscience Trials Australia | 3 |
| Cardurion Pharmaceuticals, Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Amgen | 1 |
| Bayer | 1 |
| Eli Lilly and Company | 1 |
| HONYA Medical Co Ltd | 1 |
| KAI Pharmaceuticals | 1 |
| Pulmovant, Inc. | 1 |
| Respira Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 14 |
| Vascular Diseases | 6 |
| Atherosclerosis | 3 |
| Brain Diseases | 3 |
| Central Nervous System Diseases | 3 |
| Cerebrovascular Disorders | 3 |
| Heart Diseases | 3 |
| Lung Diseases | 3 |
| Nervous System Diseases | 3 |
| Stroke | 3 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.